AI Could Reshape Clinical Trials—and the Business of Pharma | TIME
... AI's risks , so governments might more effectively manage them. But with the world's frontrunner in the AI race not signing its name to the report ...
- Topics
- HealthcareGovernment & Public Sector
- Tracked via
- “AI Risks”